J01DD14 - Ceftibuten |
Probably not porphyrinogenic |
PNP |
Rationale
Probably not significantly metabolised. No data pointing to CYP-interaction.
Chemical description
Betalactamase stable antibiotic of cephalosporine type used in urinary tract infections, exacerbations of chronic bronchitis and in acute sinusitis, otitis media and pharyngotonsillitis where penicillins are ineffective. Metabolized only to a small extent, excreted by the kidneys in unchanged form. No indications for CYP-interaction.
IPNet drug reports
Uneventful use reported in 2 patients with acute porphyria.
Similar drugs
References
| # | Citation details | PubMed ID |
|---|---|---|
| Porphyria Drug Lists | ||
| 1. | South African List
Porphyria South Africa No longer maintained
|
|
Tradenames
Isocef 
Cedax · Isocef · Wincef 
Creabil 
Cedax 
Cedax · Ceftibuten component of · Seftem 
Ceftibutene 
Ceftibuteno 
Ceftibuten